Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Target not currently curated in GtoImmuPdb
Target id: 2165
Nomenclature: phosphatidylinositol-4-phosphate 5-kinase type 1 gamma
Abbreviated Name: PIP5K1C
Family: Type I PIP kinases (1-phosphatidylinositol-4-phosphate 5-kinase family), Phosphatidylinositol phosphate kinases
Gene and Protein Information ![]() |
||||||
| Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
| Human | - | 668 | 19p13.3 | PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase type 1 gamma | |
| Mouse | - | 661 | 10 C1 | Pip5k1c | phosphatidylinositol-4-phosphate 5-kinase, type 1 gamma | |
| Rat | - | 688 | 7q11 | Pip5k1c | phosphatidylinositol-4-phosphate 5-kinase type 1 gamma | |
Previous and Unofficial Names ![]() |
| PIP5K1-gamma | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma | phosphatidylinositol-4-phosphate 5-kinase |
Database Links ![]() |
|
| Alphafold | O60331 (Hs), O70161 (Mm), Q5I6B8 (Rn) |
| BRENDA | 2.7.1.68 |
| CATH/Gene3D | 3.30.800.10, 3.30.810.10 |
| ChEMBL Target | CHEMBL1908383 (Hs) |
| Ensembl Gene | ENSG00000186111 (Hs), ENSMUSG00000034902 (Mm), ENSRNOG00000020577 (Rn) |
| Entrez Gene | 23396 (Hs), 18717 (Mm), 314641 (Rn) |
| Human Protein Atlas | ENSG00000186111 (Hs) |
| KEGG Enzyme | 2.7.1.68 |
| KEGG Gene | hsa:23396 (Hs), mmu:18717 (Mm), rno:314641 (Rn) |
| OMIM | 606102 (Hs) |
| Orphanet | ORPHA160322 (Hs) |
| Pharos | O60331 (Hs) |
| RefSeq Nucleotide | NM_001195733 (Hs), NM_001146687 (Mm), NM_001033970 (Rn) |
| RefSeq Protein | NP_036530 (Hs), NP_001140159 (Mm), NP_001029142 (Rn) |
| UniProtKB | O60331 (Hs), O70161 (Mm), Q5I6B8 (Rn) |
| Wikipedia | PIP5K1C (Hs) |
Selected 3D Structures ![]() |
|||||||||||
|
|
||||||||||
Enzyme Reaction ![]() |
||||
|
||||
DiscoveRx KINOMEscan® screen ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1,3 |
![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Target used in screen: PIP5K1C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displaying the top 10 most potent ligands View all ligands in screen » | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinically-Relevant Mutations and Pathophysiology
|
||||||||||
|
||||||||||
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Kahlfeldt N, Vahedi-Faridi A, Koo SJ, Schäfer JG, Krainer G, Keller S, Saenger W, Krauss M, Haucke V. (2010) Molecular basis for association of PIPKI gamma-p90 with clathrin adaptor AP-2. J Biol Chem, 285 (4): 2734-49. [PMID:19903820]
3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
Type I PIP kinases (1-phosphatidylinositol-4-phosphate 5-kinase family): phosphatidylinositol-4-phosphate 5-kinase type 1 gamma. Last modified on 13/08/2015. Accessed on 30/10/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2165.